However, Wedbush’s team said Musk has a good track record of balancing multiple initiatives and accelerating innovation at Tesla. Put simply, Wedbush views these as containable brand issues that ...

Geoffrey Maxwell, the former Jamaica national player and coach, has died. He passed away on Saturday morning after a battle with Alzheimer’s disease. Maxwell represented Jamaica as a defender ...

Wedbush currently has a “Outperform” rating and a $36.00 target price on the stock. The consensus estimate for Arcus Biosciences’ current full-year earnings is ($3.20) per share.

Wedbush currently has a “Outperform” rating and a $7.00 price target on the stock. The consensus estimate for Chimerix’s current full-year earnings is ($0.99) per share. Get Chimerix alerts: ...

Investing.com -- Tesla's stock has faced continued pressure in 2025, but Wedbush analysts remain bullish, maintaining their Outperform rating and $550 price target on the stock. While concerns ...

However, Wedbush Securities sees the reaction as overblown. Analyst Dan Ives and his team argue that instead of hurting Palantir, the proposed cuts could actually work in its favor. With the ...

Wedbush analyst Dan Ives has been one of the early backers of Palantir. Safe to say, his pick has been a success. Now, as Ives continues to remain bullish on the company, he is eyeing another ...

Wedbush made a splash on Tuesday with the announcement that it was entering the ever-growing exchange-traded fund market. With more than 7K ETFs listed globally, collectively managing over $10T in ...

LOS ANGELES, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Wedbush, a Los Angeles-based financial services firm with global reach, and a legacy of innovation and client-focused investment solutions ...

LOS ANGELES, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Wedbush, a Los Angeles-based financial services firm with global reach, and a legacy of innovation and client-focused investment solutions, introduces ...